Literature DB >> 10376527

Role of the ATFa/JNK2 complex in Jun activation.

F De Graeve1, A Bahr, K T Sabapathy, C Hauss, E F Wagner, C Kedinger, B Chatton.   

Abstract

The ATFa proteins, which are members of the CREB/ATF family of transcription factors, display quite versatile properties. We have previously shown that they interact with the adenovirus E1a oncoprotein, mediating part of its transcriptional activity and heterodimerize with the Jun, Fos or related transcription factors, thereby modulating their DNA-binding specificity. In the present study, we report the sequence requirement of the N-terminal activation domain of ATFa and demonstrate the importance of specific threonine residues (Thr51 and Thr53) in addition to that of the metal-binding domain, in transcriptional activation processes. We also show that the N-terminal domain of ATFa which stably binds the Jun N-terminal kinase-2 (JNK2) (Bocco et al., 1996), is not a substrate for this kinase in vivo but, instead, serves as a JNK2-docking site for ATFa-associated partners like JunD, allowing them to be phosphorylated by the bound kinase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10376527     DOI: 10.1038/sj.onc.1202723

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

2.  ATF7 is stabilized during mitosis in a CDK1-dependent manner and contributes to cyclin D1 expression.

Authors:  Etienne Schaeffer; Marc Vigneron; Annie-Paule Sibler; Mustapha Oulad-Abdelghani; Bruno Chatton; Mariel Donzeau
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  ATF2 translation is induced under chemotherapeutic drug-mediated cellular stress via an IRES-dependent mechanism in human hepatic cancer Bel7402 cells.

Authors:  Qi Li; Wen-Qing Gao; Wen-Yan Dai; Chuang Yu; Rui-Yu Zhu; Jian Jin
Journal:  Oncol Lett       Date:  2016-10-18       Impact factor: 2.967

4.  Drosophila activating transcription factor-2 is involved in stress response via activation by p38, but not c-Jun NH(2)-terminal kinase.

Authors:  Yuji Sano; Hiroshi Akimaru; Tomoo Okamura; Tomoko Nagao; Masahiro Okada; Shunsuke Ishii
Journal:  Mol Biol Cell       Date:  2005-03-23       Impact factor: 4.138

5.  Social isolation stress induces ATF-7 phosphorylation and impairs silencing of the 5-HT 5B receptor gene.

Authors:  Toshio Maekawa; Seungjoon Kim; Daisuke Nakai; Chieko Makino; Tsuyoshi Takagi; Hiroo Ogura; Kazuyuki Yamada; Bruno Chatton; Shunsuke Ishii
Journal:  EMBO J       Date:  2009-11-05       Impact factor: 11.598

Review 6.  Inheritance and memory of stress-induced epigenome change: roles played by the ATF-2 family of transcription factors.

Authors:  Ki-Hyeon Seong; Toshio Maekawa; Shunsuke Ishii
Journal:  Genes Cells       Date:  2012-03-01       Impact factor: 1.891

7.  MAP Kinases and Prostate Cancer.

Authors:  Gonzalo Rodríguez-Berriguete; Benito Fraile; Pilar Martínez-Onsurbe; Gabriel Olmedilla; Ricardo Paniagua; Mar Royuela
Journal:  J Signal Transduct       Date:  2011-10-20

8.  A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.

Authors:  Jessica Diring; Barbara Camuzeaux; Mariel Donzeau; Marc Vigneron; Manuel Rosa-Calatrava; Claude Kedinger; Bruno Chatton
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

9.  Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity.

Authors:  Pierre-Jacques Hamard; Michaël Boyer-Guittaut; Barbara Camuzeaux; Denis Dujardin; Charlotte Hauss; Thomas Oelgeschläger; Marc Vigneron; Claude Kedinger; Bruno Chatton
Journal:  Nucleic Acids Res       Date:  2007-01-30       Impact factor: 16.971

10.  Cdk1-mediated phosphorylation of human ATF7 at Thr-51 and Thr-53 promotes cell-cycle progression into M phase.

Authors:  Hitomi Hasegawa; Kenichi Ishibashi; Shoichi Kubota; Chihiro Yamaguchi; Ryuzaburo Yuki; Haruna Nakajo; Richard Eckner; Noritaka Yamaguchi; Kazunari K Yokoyama; Naoto Yamaguchi
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.